Literature DB >> 16827897

The fate of effector CD8 T cells in vivo is controlled by the duration of antigen stimulation.

Xiaopei Huang1, Yiping Yang.   

Abstract

What controls the fate of the T-cell response remains incompletely defined. Gain of effector function facilitated by costimulation has been thought to be a crucial factor in determining the outcome of the T-cell response, i.e. long-term memory in the presence of costimulation versus tolerance induction in the absence of costimulation. In this study, we show that while costimulation or cognate CD4 helps to promote the acquisition of effector function during the initial phase of the CD8 T-cell response, the fate of effector CD8 T cells is controlled by the duration of subsequent antigenic stimulation. Effector CD8 T cells differentiate into memory cells only after clearance of antigen, whereas in the presence of persistent antigen, effector CD8 T cells are tolerized. Furthermore, protective immunity against tumour cannot develop in the persisting antigen environment. These results suggest that removal of persisting antigen by other means might be a prerequisite for effective immunotherapy in cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16827897      PMCID: PMC1782300          DOI: 10.1111/j.1365-2567.2006.02381.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  52 in total

1.  A simplified system for generating recombinant adenoviruses.

Authors:  T C He; S Zhou; L T da Costa; J Yu; K W Kinzler; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

2.  Induction of antigen-specific T cell anergy: An early event in the course of tumor progression.

Authors:  K Staveley-O'Carroll; E Sotomayor; J Montgomery; I Borrello; L Hwang; S Fein; D Pardoll; H Levitsky
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

3.  CD8(+) T cell-mediated spontaneous diabetes in neonatal mice.

Authors:  D J Morgan; R Liblau; B Scott; S Fleck; H O McDevitt; N Sarvetnick; D Lo; L A Sherman
Journal:  J Immunol       Date:  1996-08-01       Impact factor: 5.422

Review 4.  Models of T cell anergy: is there a common molecular mechanism?

Authors:  R H Schwartz
Journal:  J Exp Med       Date:  1996-07-01       Impact factor: 14.307

5.  CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40.

Authors:  Y Yang; J M Wilson
Journal:  Science       Date:  1996-09-27       Impact factor: 47.728

6.  Functional impairment of CD8(+) T cells by regulatory T cells during persistent retroviral infection.

Authors:  Ulf Dittmer; Hong He; Ronald J Messer; Simone Schimmer; Anke R M Olbrich; Claes Ohlen; Philip D Greenberg; Ingunn M Stromnes; Michihiro Iwashiro; Shimon Sakaguchi; Leonard H Evans; Karin E Peterson; Guojun Yang; Kim J Hasenkrug
Journal:  Immunity       Date:  2004-03       Impact factor: 31.745

7.  CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells.

Authors:  A J Adler; D W Marsh; G S Yochum; J L Guzzo; A Nigam; W G Nelson; D M Pardoll
Journal:  J Exp Med       Date:  1998-05-18       Impact factor: 14.307

8.  Viral immune evasion due to persistence of activated T cells without effector function.

Authors:  A J Zajac; J N Blattman; K Murali-Krishna; D J Sourdive; M Suresh; J D Altman; R Ahmed
Journal:  J Exp Med       Date:  1998-12-21       Impact factor: 14.307

9.  Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation.

Authors:  M Cella; D Scheidegger; K Palmer-Lehmann; P Lane; A Lanzavecchia; G Alber
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

10.  The peripheral deletion of autoreactive CD8+ T cells induced by cross-presentation of self-antigens involves signaling through CD95 (Fas, Apo-1).

Authors:  C Kurts; W R Heath; H Kosaka; J F Miller; F R Carbone
Journal:  J Exp Med       Date:  1998-07-20       Impact factor: 14.307

View more
  6 in total

1.  CD62L- memory T cells enhance T-cell regeneration after allogeneic stem cell transplantation by eliminating host resistance in mice.

Authors:  Jifeng Zhang; Brice E Barefoot; Wenjian Mo; Divino Deoliveira; Jessica Son; Xiuyu Cui; Elizabeth Ramsburg; Benny J Chen
Journal:  Blood       Date:  2012-05-17       Impact factor: 22.113

2.  Allospecific CD4(+) effector memory T cells do not induce graft-versus-host disease in mice.

Authors:  Ping Zhang; Jieying Wu; Divino Deoliveira; Nelson J Chao; Benny J Chen
Journal:  Biol Blood Marrow Transplant       Date:  2012-07-15       Impact factor: 5.742

3.  Intrinsic IL-21 signaling is critical for CD8 T cell survival and memory formation in response to vaccinia viral infection.

Authors:  Patricia Novy; Xiaopei Huang; Warren J Leonard; Yiping Yang
Journal:  J Immunol       Date:  2011-01-21       Impact factor: 5.422

4.  Induction of type I IFN is required for overcoming tumor-specific T-cell tolerance after stem cell transplantation.

Authors:  Ian Horkheimer; Michael Quigley; Jiangao Zhu; Xiaopei Huang; Nelson J Chao; Yiping Yang
Journal:  Blood       Date:  2009-03-11       Impact factor: 22.113

5.  In situ vaccine, immunological memory and cancer cure.

Authors:  Kangla Tsung; Jeffrey A Norton
Journal:  Hum Vaccin Immunother       Date:  2015-09-11       Impact factor: 3.452

Review 6.  Tumor reductive therapies and antitumor immunity.

Authors:  Huiqin Guo; Kangla Tsung
Journal:  Oncotarget       Date:  2017-06-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.